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Assessment of the Validity of Reported Antibiotic 
Allergic Reactions in Pediatric Patients 
Lauren E. Miller, Pharm.D., Chad A. Knoderer, Pharm.D., Elaine g. Cox, M.D., and 
Martin B. Kleiman, M.D. 
Study Objective. To determine whether a reported antibiotic allergy was 
likely to have been immunologically mediated. 
 
Design. Questionnaire-based study. 
 
Setting. Tertiary care, freestanding children’s hospital. 
 
Patients. One hundred patients aged 1 month–18 years for whom guardians reported an allergy to an 
antibiotic at the time of hospital admission between October 2009 and March 2010. 
 
Intervention. guardians of the patients were interviewed by using a standardized allergy assessment 
questionnaire. 
 
Measurements and Main Results. Based on answers to the questionnaire, the reported allergic reactions 
were categorized to determine if they were true allergies or adverse reactions. Among the 100 patients, 
reported allergies were categorized as immunologically mediated reactions in 58%, non–immunologically 
mediated adverse drug reactions in 27%, no reaction in 3%, and unknown in 12%. Reactions to 
penicillins, cephalosporins, or sulfonamides were reported most frequently and were attributed to 
immunologically mediated reactions in 68% (26/38), 74% (17/23), and 67% (10/15) of instances, 
respectively. 
 
Conclusion. Use of the allergy assessment questionnaire determined that 58% of the 100 reported 
antibiotic allergies fulfilled criteria for an immunologically mediated reaction. These findings underscore 
the utility of an allergy assessment questionnaire, versus a simple drug history, in improving the accuracy 
of reported antibiotic reactions. 
 
Allergic reactions are thought to be responsible for 6–10% of adverse reactions to drugs and can 
be acute, serious, or life-threatening.1 Drug reactions are considered allergic if they are 
immunologically mediated, as defined by the gell and Coombs classification (Table 1).1 
Allergies to penicillin account for 5–20% of the reported drug reactions.2, 3 Approximately 10–
30% of patient-reported antibiotic allergies have been found not to be immunologically 
mediated.2–8 We are aware of no studies that have addressed the validity of reported drug 
reactions in children, and none that have used a questionnaire to assess the validity of reported 
reactions.2–8 
 
Although parents or guardians often recall being informed by a health care professional that their 
child has an antibiotic allergy, many cannot accurately describe the details of these drug 
reactions. In these settings, parents and health care professionals are often reticent to administer 
the antibiotic or agents in the same drug class. In most instances, caregivers are unable to 
distinguish non–immunologically mediated adverse drug reactions from those likely to be 
allergic reactions. Thereafter, when queried by health care providers, such intolerances may be 
recorded as drug allergies. Both overreporting and documentation within the medical record 
often result in use of alternative agents with wider antimicrobial spectra, narrower safety 
profiles, and/or higher costs. 
 
The objective of this study was to determine whether a reported antibiotic allergy was likely to 
have been immunologically mediated by using an allergy assessment questionnaire. 
 
Table 1 Gell and Coombs Classification of Allergic Reactions1 
Type Reaction Name Description Time to Onset 
I Anaphylactic 
(IgE mediated) 
Allergen binds to IgE on basophils or mast cells and causes 
inflammatory 
mediators. This results in anaphylaxis, edema, and 
bronchospasm. 
Anaphylaxis can involve a single organ or multiple organs, 
including 
the respiratory tract, nasal mucosa, skin, or gastrointestinal tract. 
Rapid 
(within 30 min) 
II Cytotoxic Reaction involves destruction of host cells, usually blood cells, 
through 
cell-associated antigens that initiate cytolysis by antigen-specific 
antibodies. 
This can result in hemolytic anemia, agranulocytosis, or 
thrombocytopenia. 
5–12 hrs 
III Immune 
complexes 
Antigen-antibody complexes form and deposit on blood vessel 
walls. 
This activates complement and causes localized edematous or 
erythematous 
reactions or serum sickness. 
3–8 hrs 
IV Cell mediated Antigens activate lymphocytes, which release inflammatory 
mediators, leading 
to dermatologic manifestations involving erythema and 
indurations. 
24–48 hrs 
IgE = immunoglobulin E. 
 
 
Methods 
Study Population and Setting 
 
This study was conducted after receiving approval from the institutional review board of Indiana 
University–Purdue University, Indianapolis, Indiana. Eligible patients were those aged 1 month–
18 years who, on admission to a tertiary pediatric hospital, were reported by a parent or guardian 
to have previously experienced an allergic reaction to an antibiotic. Exclusion criteria were 
patients in the neonatal intensive care unit, those who were readmitted after initial study 
inclusion, and patients whose medical records described adverse reactions that were unlikely to 
have been immunologically mediated (i.e., vancomycin with a listed reaction of red man’s 
syndrome or macrolide antibiotics in patients receiving cyclosporine or tacrolimus) as 
determined by study investigators. 
 
One hundred patients were selected by using a randomly generated list of hospital room numbers 
from among those reporting a history of an antibiotic allergy when being admitted from October 
2009 through March 2010. All patients’ guardians were interviewed by one pharmacist using a 
standardized allergy assessment questionnaire (Appendix 1), which was derived from a 
compilation of recommendations for obtaining an accurate allergy history.2, 4–8 
 
Drug reactions were categorized as either a true allergy or an adverse reaction. Drug reactions 
that were likely to have been immunologically mediated were considered true allergies as 
defined by the assessment questionnaire. An adverse reaction was presumed probable if either all 
reported symptoms were included within the adverse reaction column of the assessment 
questionnaire, or an antibiotic in the same class (penicillin or cephalosporin) had subsequently 
been administered without the development of an allergic reaction. For example, if a patient had 
a reported allergy to penicillin, but had subsequently received amoxicillin without a reaction, the 
reaction to penicillin would be considered an adverse reaction. Adverse reactions that were 
considered non–immunologically mediated included vomiting and/or diarrhea, behavioral 
changes, muscle cramps, or urinary tract symptoms. 
 
Drug reactions were considered “unknown” if not directly observed by the guardian or if the 
interval between the reaction and antibiotic administration was unclear. “No reaction” was 
recorded if the patient had never received the drug or was receiving the drug at the time of the 
interview and no reaction occurred. 
 
Guardians were also queried as to whether the allergic reaction had been“confirmed.” This was 
defined if the guardian recalled being told by a physician or other health care provider that the 
patient was allergic to the drug. Skin or other challenge tests were not performed. 
 
Statistical Analysis 
 
Descriptive statistics were used for patient demographics, the percentage of reported antibiotic 
allergies that were assessed to have been true allergies, and the occurrence of true allergies 
among the antibiotic classes. Statistical analysis was conducted with the Statistical Package for 
Social Sciences, version 16.0 (SPSS, Inc., Chicago, IL) and Excel 2007 (Microsoft Corp., 
Redmond, WA). 
 
Results 
Patient demographics are summarized in Table 2. guardian-reported reactions in the 100 patients 
were categorized as true allergy in 58%, adverse reaction in 27%, no reaction in 3%, and 
unknown in 12%. The reactions were categorized as unknown based on the following criteria: no 
recollection of the signs or symptoms (five patients); receipt of multiple antibiotics when the 
reaction occurred (three patients); patient was readmitted to the hospital after undergoing 
treatment, and it was unclear whether symptoms resulted from an allergic reaction or were 
attributable to the primary illness (one patient); guardian did not recall the events leading to the 
history of allergy (one patient); guardian told by primary physician that reaction should be listed 
as allergy (one patient); and guardian recalled being told that the patient had an allergic reaction, 
but guardian did not recall the name of the drug (one patient). Medical record–documented drug 
allergies were most commonly attributed to the penicillin class, cephalosporins, and/or 
sulfonamides (Table 3); these reactions were categorized as immunologically mediated in 68%, 
74%, and 67%, respectively. 
 
 
 
 
 
Table 2 Demographics of the Study Children 
Characteristic Value 
 Mean •±  SD 
Age on admission, yrs (n=100) 
Age when allergic reaction occurred, 
yrs (n=87) 
8.77 ± 4.76 
4.48 ± 3.82 
 Percentage of 
Patients 
(n=100) 
Age group 
1 mo–5 yrs 
6–11 yrs 
12–17 yrs 
Male 
Interviewee 
Mother 
Father 
Both parents 
Other guardian 
Medical record–documented 
antibiotic 
Specific drug 
Drug class 
Specific reaction documented in 
medical 
record 
 
27 
37 
36 
57 
 
81 
13 
1 
5 
 
91 
9 
33 
 
 
A reaction was recalled by 87 of the 100 guardians interviewed. Among the 87 reported 
reactions, 40 (46%) were hives or blistering and 39 (45%) were rashes (Table 3). Sixteen patients 
(18%) were reported to have had both reactions. The interval between drug administration and 
reaction onset was known in 33 (83%) of the 40 hives or blistering reactions and 31 (79%) of the 
39 instances of rash. Of these 33 hives or blistering reactions, 19 (58%) occurred with the first 
dose and 14 (42%) occurred later in therapy. Of these 31 instances of rash, 12 (39%) occurred 
after the first dose, 17 (55%) occurred later in treatment, and 2 (6%) occurred after treatment. 
Rash was most commonly reported with penicillin antibiotics (18/39 [46%]), followed by 
sulfonamides (8/39 [21%]), and cephalosporins (7/39 [18%]). guardians reported that the 
reaction was confirmed as a true immunologically mediated reaction in 67 (77%) of the 87 
instances, with 36% resulting from a physician visit, 12% over the phone, 16% in an emergency 
room visit or at another hospital, and 13% at the study hospital. There were no reports of skin 
testing. 
 
Discussion 
 
Pharmacists and physicians often rely on the guardian’s recollection within the medical record 
documentation to assess the validity of reported allergies to drugs. The terms “rash” and “hives” 
are often defined differently by guardians and health care professionals. The results of such 
inquiries into reported allergies must be objectively interpreted since many are found not to be 
immunologically mediated. Revalidation of these reports should be conducted at each encounter.  
 
Inaccurate classification of adverse drug reactions as immunologically mediated reactions has 
been shown to result in substitution of agents with wider spectra of activity, narrower safety 
profiles, and higher costs.3, 8 Such reports have been shown to alter antibiotic selection in 30% 
of patients.8 Cross-sensitivity to cephalosporins in patients allergic to penicillin has been 
reported in as few as 0.5% of patients.9 However, many believe that the range of cross-
sensitivity to cephalosporins is higher (8–18%) among patients with penicillin allergy, resulting 
in limitation of use of penicillins, cephalosporins, and potentially carbapenems from an antibiotic 
regimen.9 
 
A study performed in an adult acute-care teaching hospital found that 28% of allergy labels 
could be removed after analyzing the results of a drug allergy assessment.4 Similar studies have 
concluded that patient-reported drug allergies were found to be valid in 22–50% of instances.2, 
4, 5 Similar to our findings, another group of authors determined that β-lactam antibiotics and 
sulfonamides accounted for 63% of patient- reported allergies, but, in 9% of cases, the patients 
were found either to be nonallergic or to have not received the drug.6 
 
Our assessment questionnaire examined guardian-recalled historical information in a consistent 
fashion, which was used to assess the probability of a patient having an immunologically 
mediated drug reaction. Both for the purpose of our analysis and in an effort to simplify our 
questionnaire, a detailed description of rashes was not used, rather the presence or absence of 
cutaneous reactions was noted. Since viral exanthems are common causes of fever in children, it 
is difficult to differentiate rashes caused by infection and drug allergy.3 One group of authors 
reported penicillin-associated rashes in 7% of treated children; however, those considered 
immunologically mediated occurred in only about 3% of treated children.10 The percentage of 
immunologically mediated drug reactions found in our study (58%) may have been 
overestimated, since rashes due to the primary disease process could have been attributed to true 
allergies. 
 
Guardians reported that being told by aphysician or other health care provider that their child had a drug 
allergy and/or having a physician prescribe an alternative antibiotic was interpreted as validation of a drug 
allergy. A study that used skin testing and oral antibiotic challenge to confirm immunologically mediated 
antibiotic reaction found that only 34% of immunologically mediated reactions to penicillins and 
cephalosporins can be accurately predicted by the appearance of the rash at the time of the presumed 
reaction.11 guardians reported that in 12% of instances, confirmation or validation of allergic reactions was 
based solely on telephone conversations with  a care provider. In these instances, guardians should be 
informed that further evaluation, with use of skin testing or oral challenge, may more accurately assess 
the validity of the reaction. 
 
 
 
 
 
 
 
 
 
 
 
 
                                       Table 3 Characterization of Antibiotic Reaction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Variable Percentage of 
Patients with 
Reaction 
(n=100) 
No. (%) of 
Reactions 
Categorized as 
Immunologically 
Mediated 
Medical record– 
documented drug 
allergy 
Penicillins 
Cephalosporins 
Sulfonamides 
Macrolides 
Vancomycin 
Clindamycin 
Fluoroquinolone 
Metronidazole 
 
 
 
40 
25 
18 
9 
4 
2 
1 
1 
 
 
 
26 (68) 
17 (74) 
10 (67) 
2 (25) 
1 (33) 
1 (100) 
0 (0) 
1 (100) 
 (n=87)  
Guardian-described 
Reaction3 
Hives or blistering 
Diffuse rash 
Otherb 
Unknown 
Nausea or vomiting 
Severe itching 
Diarrhea 
Shortness of breath 
Anaphylaxis 
Serum sickness 
Drowsiness 
Headache 
Irritability 
Muscle cramps 
 
 
46 
45 
29 
15 
10 
10 
8 
8 
3 
3 
2 
< 1 
< 1 
< 1 
 
 (n=100)  
Time to reaction onset 
First dose 
During therapy 
After completion 
of therapy 
Unknown 
Antibiotic 
rechallenged 
Yes 
No 
Unknown 
 
33 
35 
2 
 
30 
 
 
17 
75 
8 
 
 No. (%) of 17 
Rechallenges 
 
Repeat reaction 
during rechallenge 
Yes 
No 
Unknown 
 
 
14 (82) 
2 (12) 
1 (6) 
 
aMultiple reaction symptoms were reported by some guardians. 
bIncluded elevated transaminase levels, red man’s syndrome, diaper rash, intestinal bleeding, 
flushing, redness at the injection site, swelling, erythema multiforme, raw and painful skin, facial 
rash, and seizure. 
 
 Limitations 
 
A potential limitation of this study could have been a guardian’s inaccurate recollection and/or description 
of the rash, as well as the recollection of the temporal sequence of events. A previously published 
assessment of the validity of antibiotic allergies found that 98% of patients recalled the name of the drug 
and the nature of the allergic reaction.8 In our study, 87% of the 100 guardians could describe the child’s 
reaction. The reports of “false-positive” allergies to antibiotics other than penicillins, cephalosporins, and 
sulfonamides appear high, but the percentage of those reports was low at 17%. This may be attributed to 
the imprecise documentation in the medical record leading to the false-positive allergy. In addition, 12% 
of 100 reactions were categorized as unknown because limited information was available (i.e., the 
guardian did not recall specific details) to determine if the reactions were likely to be immunologically 
mediated. 
 
Conclusion 
 
An allergy assessment questionnaire found that 58% of 100 reported antibiotic allergies fulfilled criteria 
for an immunologically mediated reaction. There are opportunities to improve the assessment and 
documentation of reported antibiotic allergies in pediatric patients. Use of an allergy assessment 
questionnaire may reveal discrepancies necessitating further evaluation, which may impact antibiotic 
utilization. 
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